» Articles » PMID: 26883161

Sleep Propensity in Psychiatric Hypersomnolence: A Systematic Review and Meta-analysis of Multiple Sleep Latency Test Findings

Overview
Journal Sleep Med Rev
Date 2016 Feb 18
PMID 26883161
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Hypersomnolence plays a sizeable role in the course and morbidity of psychiatric disorders. Current sleep medicine nosology is reliant on the multiple sleep latency test (MSLT) to segregate hypersomnolence associated with psychiatric disorders from other central nervous system causes. However, the evidence base regarding sleep propensity in psychiatric hypersomnolence as measured by the MSLT has not been systematically evaluated, which is vital to clarify the utility and validity of current nosological schema. In this review, the use of sleep propensity assessed by the MSLT in patients with psychiatric hypersomnolence is systematically evaluated, using both qualitative and quantitative assessment. Findings demonstrate high heterogeneity and potential for bias among studies, with a pooled estimate of sleep propensity among patients with psychiatric hypersomnolence similar to normative values. Additionally, approximately 25% of patients with psychiatric hypersomnolence demonstrate a mean sleep latency below 8 min, the current cutpoint to define pathologic sleepiness. These data underscore the limitations of the MSLT in segregating psychiatric hypersomnolence from other central nervous system hypersomnias. Further research is warranted to evaluate novel measures and biomarkers of excessive sleepiness to advance clinical practice, as well as dimensional approaches to classification of hypersomnolence disorders.

Citing Articles

Pathophysiological Models of Hypersomnolence Associated With Depression.

Moderie C, Boivin D Biol Psychiatry Glob Open Sci. 2025; 5(2):100445.

PMID: 39935825 PMC: 11810709. DOI: 10.1016/j.bpsgos.2024.100445.


A study on differences about the influencing factors of depressive symptoms between medical staff and residents during 2022 city-wide temporary static management period to fighting against COVID-19 pandemic in Shanghai.

Zhao Y, Tao Y, Bao X, Ding Q, Han C, Luo T Front Public Health. 2023; 10:1083144.

PMID: 36699891 PMC: 9868696. DOI: 10.3389/fpubh.2022.1083144.


Central disorders of hypersomnolence: diagnostic discrepancies between military and civilian sleep centers.

Thomas C, Vattikuti S, Shaha D, Werner J, Hansen S, Collen J J Clin Sleep Med. 2022; 18(10):2433-2441.

PMID: 35855527 PMC: 9516578. DOI: 10.5664/jcsm.10144.


The growing toolkit for evaluation of central disorders of hypersomnolence.

Plante D Sleep. 2022; 45(6).

PMID: 35176157 PMC: 9189963. DOI: 10.1093/sleep/zsac040.


Self-reported symptoms and objective measures in idiopathic hypersomnia and hypersomnia associated with psychiatric disorders: a prospective cross-sectional study.

Buskova J, Novak T, Miletinova E, Kralova R, Kost Alova J, Klikova M J Clin Sleep Med. 2021; 18(3):713-720.

PMID: 34605393 PMC: 8883091. DOI: 10.5664/jcsm.9702.


References
1.
Fitzgerald C, Messias E, Buysse D . Teen sleep and suicidality: results from the youth risk behavior surveys of 2007 and 2009. J Clin Sleep Med. 2011; 7(4):351-6. PMC: 3161767. DOI: 10.5664/JCSM.1188. View

2.
Trotti L, Saini P, Freeman A, Bliwise D, Garcia P, Jenkins A . Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. J Psychopharmacol. 2013; 28(7):697-702. DOI: 10.1177/0269881113515062. View

3.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J . Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003; 73(9):712-6. DOI: 10.1046/j.1445-2197.2003.02748.x. View

4.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

5.
Aldrich M, Chervin R, Malow B . Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep. 1997; 20(8):620-9. View